Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 28:15:100235.
doi: 10.1016/j.lrr.2021.100235. eCollection 2021.

Fludarabine-based salvage therapy for refractory/relapsed acute leukemias: A single center experience

Abdul Muqtadir Abbasi  1 , Usman Shaikh  2 , Natasha Ali  2 , Mohammad Nadir Haider  3
Affiliations

Fludarabine-based salvage therapy for refractory/relapsed acute leukemias: A single center experience

Abdul Muqtadir Abbasi et al. Leuk Res Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors do not declare any relevant conflicts of interests.

Figures

Fig. 1
Fig. 1
Kaplan Meier life table stratified by Fludarabine-based treatment regimen. Log rank test comparing survival function χ2 = 0.18, p = 0.671.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Oriol A., Vives S., Hernández-Rivas J.-.M., Tormo M., Heras I., Rivas C. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica. 2010;95(4):589–596. - PMC - PubMed
    1. Freund M., Diedrich H., Gamer A., Gramatzki M., Heil G., Heyll A. Treatment of relapsed or refractory adult acute lymphocytic leukemia. Cancer. 1992;69(3):709–716. - PubMed
    1. Giona F., Testi A.M., Annino L., Amadori S., Arcese W., Camera A. Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP* experience. Br. J. Haematol. 1994;86(1):55–61. - PubMed
    1. Specchia G., Pastore D., Carluccio P., Liso A., Mestice A., Rizzi R. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia. Ann. Hematol. 2005;84(12):792–795. 2005/12/01. - PubMed
    1. Pastore D., Specchia G., Carluccio P., Liso A., Mestice A., Rizzi R. FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. Ann. Hematol. 2003;82(4):231–235. 2003/04/01. - PubMed

LinkOut - more resources